175 related articles for article (PubMed ID: 8209865)
21. Hodgkin cells accumulate mRNA for bcl-2.
Hell K; Lorenzen J; Fischer R; Hansmann ML
Lab Invest; 1995 Oct; 73(4):492-6. PubMed ID: 7474920
[TBL] [Abstract][Full Text] [Related]
22. Single-cell analysis of the t(14;18)(q32;q21) chromosomal translocation in Hodgkin's disease demonstrates the absence of this translocation in neoplastic Hodgkin and Reed-Sternberg cells.
Gravel S; Delsol G; Al Saati T
Blood; 1998 Apr; 91(8):2866-74. PubMed ID: 9531597
[TBL] [Abstract][Full Text] [Related]
23. The detection of specific gene rearrangements in non-Hodgkin's lymphoma using the polymerase chain reaction.
Corbally N; Grogan L; Dervan PA; Carney DN
Br J Cancer; 1992 Nov; 66(5):805-9. PubMed ID: 1419624
[TBL] [Abstract][Full Text] [Related]
24. Frequency and structure of t(14;18) major breakpoint regions in non-Hodgkin's lymphomas typed according to the Kiel classification: analysis by direct DNA sequencing.
Kneba M; Eick S; Herbst H; Willigeroth S; Pott C; Bolz I; Bergholz M; Neumann C; Stein H; Krieger G
Cancer Res; 1991 Jun; 51(12):3243-50. PubMed ID: 2039999
[TBL] [Abstract][Full Text] [Related]
25. Rearrangement of bcl-2 is detectable in Hodgkin's disease by polymerase chain reaction.
Mitani S; Oka T; Aoki N; Hojo I; Ota U; Mori S
Jpn J Cancer Res; 1994 Dec; 85(12):1229-32. PubMed ID: 7852186
[TBL] [Abstract][Full Text] [Related]
26. All advanced stage non-Hodgkin's lymphomas with a polymerase chain reaction amplifiable breakpoint of bcl-2 have residual cells containing the bcl-2 rearrangement at evaluation and after treatment.
Gribben JG; Freedman As; Woo SD; Blake K; Shu RS; Freeman G; Longtine JA; Pinkus GS; Nadler LM
Blood; 1991 Dec; 78(12):3275-80. PubMed ID: 1742487
[TBL] [Abstract][Full Text] [Related]
27. Identification of common germinal-center B-cell precursors in two patients with both Hodgkin's disease and non-Hodgkin's lymphoma.
Bräuninger A; Hansmann ML; Strickler JG; Dummer R; Burg G; Rajewsky K; Küppers R
N Engl J Med; 1999 Apr; 340(16):1239-47. PubMed ID: 10210707
[TBL] [Abstract][Full Text] [Related]
28. Molecular analysis of the t(14;18) chromosomal translocation in malignant lymphomas.
Weiss LM; Warnke RA; Sklar J; Cleary ML
N Engl J Med; 1987 Nov; 317(19):1185-9. PubMed ID: 3657890
[TBL] [Abstract][Full Text] [Related]
29. Role of the bcl-2 oncogene in Hodgkin's disease.
Inghirami G; Frizzera G
Am J Clin Pathol; 1994 Jun; 101(6):681-3. PubMed ID: 8209851
[No Abstract] [Full Text] [Related]
30. Major and minor breakpoint sites of chromosomal translocation t(14;18) in subtypes of non-Hodgkin's lymphomas.
Klefstrom J; Franssila K; Peltomäki P; Kaartinen M; Solin ML; Knuutila S
Leuk Res; 1994 Apr; 18(4):245-50. PubMed ID: 8170168
[TBL] [Abstract][Full Text] [Related]
31. The t(2;3)(q21;q27) translocation in non-Hodgkin's lymphoma displays BCL6 mutations in the 5' regulatory region and chromosomal breakpoints distant from the gene.
Chen W; Butler M; Rao PH; Chaganti SR; Louie DC; Dalla-Favera R; Chaganti RS
Oncogene; 1998 Oct; 17(13):1717-22. PubMed ID: 9796700
[TBL] [Abstract][Full Text] [Related]
32. Expression of B-cell antigens by Hodgkin's and Reed-Sternberg cells.
Schmid C; Pan L; Diss T; Isaacson PG
Am J Pathol; 1991 Oct; 139(4):701-7. PubMed ID: 1656757
[TBL] [Abstract][Full Text] [Related]
33. The bcl-2 gene, follicular lymphoma, and Hodgkin's disease.
Cleary M; Rosenberg SA
J Natl Cancer Inst; 1990 May; 82(10):808-9. PubMed ID: 2185366
[No Abstract] [Full Text] [Related]
34. Chromosomal translocation t(14;19) as indicated by bcl-3 rearrangement is a rare phenomenon in non-Hodgkin's lymphoma and chronic lymphocytic leukemia: a molecular genetic analysis of 176 cases.
van Krieken JH; McKeithan TW; Raghoebier S; Medeiros LJ; Kluin PM; Raffeld M
Leukemia; 1990 Dec; 4(12):811-2. PubMed ID: 2243504
[TBL] [Abstract][Full Text] [Related]
35. Lymphocyte predominance Hodgkin's disease (nodular paragranuloma)--a bcl-2 negative germinal centre lymphoma.
Algara P; Martinez P; Sanchez L; Villuendas R; Orradre JL; Oliva H; Piris MA
Histopathology; 1991 Jul; 19(1):69-75. PubMed ID: 1916688
[TBL] [Abstract][Full Text] [Related]
36. 5'-->3' exonuclease-based real-time PCR assays for detecting the t(14;18)(q32;21): a survey of 162 malignant lymphomas and reactive specimens.
Estalilla OC; Medeiros LJ; Manning JT; Luthra R
Mod Pathol; 2000 Jun; 13(6):661-6. PubMed ID: 10874671
[TBL] [Abstract][Full Text] [Related]
37. Hodgkin's disease, lymphomatoid papulosis, and cutaneous T-cell lymphoma derived from a common T-cell clone.
Davis TH; Morton CC; Miller-Cassman R; Balk SP; Kadin ME
N Engl J Med; 1992 Apr; 326(17):1115-22. PubMed ID: 1532439
[TBL] [Abstract][Full Text] [Related]
38. New type of t(14;18) in a non-Hodgkin's lymphoma provides insight in molecular events in early B-cell differentiation.
Meijerink JP; Raemaekers JM; Mensink EJ
Br J Haematol; 1995 Nov; 91(3):630-9. PubMed ID: 8555066
[TBL] [Abstract][Full Text] [Related]
39. t(11;18)(q21;q21.1): a recurring translocation in lymphomas of mucosa-associated lymphoid tissue (MALT)?
Horsman D; Gascoyne R; Klasa R; Coupland R
Genes Chromosomes Cancer; 1992 Mar; 4(2):183-7. PubMed ID: 1373320
[TBL] [Abstract][Full Text] [Related]
40. Analysis of BCL2 and MYC expression in non-Hodgkin's lymphomas by in situ hybridization: correlation with chromosome translocations.
Murty VV; Ladanyi M; Houldsworth J; Mikraki V; Chaganti RS
Diagn Mol Pathol; 1992 Dec; 1(4):221-8. PubMed ID: 1342969
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
